In control and BATF3 OE cells, we detected equivalent proportions of CD8+ T cells within the tumor and circulating in peripheral blood, indicating that BATF3 OE was not improving tumor control by merely increasing T cell proliferation or tumor trafficking (Fig. 5d and Extended Data Fig. 9f). The gene discussed is CD8A; the disease is neoplasm.